Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71:96–108.

Article  Google Scholar 

Chen CJ, Chuang YC, Lin TM, Wu HY. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985;45:5895–9.

CAS  PubMed  Google Scholar 

Gerharz EW, Mansson A, Hunt S, Skinner EC, Mansson W. Quality of life after cystectomy and urinary diversion: an evidence based analysis. J Urol. 2005;174:1729–36.

Article  Google Scholar 

Alfred Witjes J, Lebret T, Compérat EM, Cowan NC, De Santis M, Bruins HM, Hernández V, Espinós EL, Dunn J, Rouanne M, Neuzillet Y, Veskimäe E, van der Heijden AG, Gakis G, Ribal MJ. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71:462–75.

CAS  Article  Google Scholar 

Fung C, Pandya C, Guancial E, Noyes K, Sahasrabudhe DM, Messing EM, Mohile SG. Impact of bladder cancer on health related quality of life in 1,476 older Americans: a cross-sectional study. J Urol. 2014;192:690–5.

Article  Google Scholar 

Ritch CR, Cookson MS, Chang SS, Clark PE, Resnick MJ, Penson DF, Smith JA Jr, May AT, Anderson CB, You C, Lee H, Barocas DA. Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy. J Urol. 2014;192:1360–4.

Article  Google Scholar 

Huang Y, Pan X, Zhou Q, Huang H, Li L, Cui X, Wang G, Jizhong R, Yin L, Xu D, Hong Y. Quality-of-life outcomes and unmet needs between ileal conduit and orthotopic ileal neobladder after radical cystectomy in a Chinese population: a 2-to-1 matched-pair analysis. BMC Urol. 2015;15:117.

Article  Google Scholar 

Allareddy V, Kennedy J, West MM, Konety BR. Quality of life in long-term survivors of bladder cancer. Cancer. 2006;106:2355–62.

Article  Google Scholar 

Gacci M, Saleh O, Cai T, Gore JL, D’Elia C, Minervini A, Masieri L, Giannessi C, Lanciotti M, Varca V, Simonato A, Serni S, Carmignani G, Carini M. Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors. Health Qual Life Outcomes. 2013;11:43.

Article  Google Scholar 

Goldberg H, Baniel J, Mano R, Rotlevy G, Kedar D, Yossepowitch O. Orthotopic neobladder vs. ileal conduit urinary diversion: a long-term quality-of-life comparison. Urol Oncol. 2016;34:121.

Article  Google Scholar 

Kikuchi E, Horiguchi Y, Nakashima J, Ohigashi T, Oya M, Nakagawa K, Miyajima A, Murai M. Assessment of long-term quality of life using the FACT-BL questionnaire in patients with an ileal conduit, continent reservoir, or orthotopic neobladder. Jpn J Clin Oncol. 2006;36:712–6.

Article  Google Scholar 

Matsuda T, Aptel I, Exbrayat C, Grosclaude P. Determinants of quality of life of bladder cancer survivors five years after treatment in France. Int J Urol. 2003;10:423–9.

Article  Google Scholar 

Mischinger J, Abdelhafez MF, Todenhofer T, Schwentner C, Aufderklamm S, Stenzl A, Gakis G. Quality of life outcomes after radical cystectomy: long-term standardized assessment of Studer Pouch versus I-Pouch. World J Urol. 2015;33:1381–7.

Article  Google Scholar 

Rouanne M, Legrand G, Neuzillet Y, Ghoneim T, Cour F, Letang N, Yonneau L, Herve JM, Botto H, Lebret T. Long-term women-reported quality of life after radical cystectomy and orthotopic ileal neobladder reconstruction. Ann Surg Oncol. 2014;21:1398–404.

Article  Google Scholar 

Takenaka A, Hara I, Soga H, Sakai I, Terakawa T, Muramaki M, Miyake H, Tanaka K, Fujisawa M. Assessment of long-term quality of life in patients with orthotopic neobladder followed for more than 5 years. Int Urol Nephrol. 2011;43:749–54.

Article  Google Scholar 

Wright JL, Porter MP. Quality-of-life assessment in patients with bladder cancer. Nat Clin Pract Urol. 2007;4:147–54.

Article  Google Scholar 

Harper A. Development of the World Health Organisation WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551–8.

Article  Google Scholar 

Huang CC, Tu SH, Lien HH, Huang CS, Wang PC, Chie WC. Conceptual structure of the Taiwan Chinese version of the EORTC QLQ-C30. Qual Life Res. 2015;24:1999–2013.

Article  Google Scholar 

Fuh JL, Wang SJ, Lu SR, Juang KD, Lee SJ. Psychometric evaluation of a Chinese (Taiwanese) version of the SF-36 health survey amongst middle-aged women from a rural community. Qual Life Res. 2000;9:675–83.

CAS  Article  Google Scholar 

Yao G, Chung CW, Yu CF, Wang JD. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc. 2002;101:342–51.

PubMed  Google Scholar 

Yao G. Development of the WHOQOL-BREF Taiwan version and the manual. The WHOQOL-Taiwan Group; 2005.

Hwang JS, Wang JD. Integrating health profile with survival for quality of life assessment. Oual Life Res. 2004;13:1–13.

Article  Google Scholar 

Hedgepeth RC, Gilbert SM, He C, Lee CT, Wood DP Jr. Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions. Urology. 2010;76:671–5.

Article  Google Scholar 

Kutner NG, Schechtman KB, Ory MG, Baker DI. Older adults’ perceptions of their health and functioning in relation to sleep disturbance, falling, and urinary incontinence. J Am Geriatr Soc. 1994;42:757–62.

CAS  Article  Google Scholar 

Tran E, Souhami L, Tanguay S, Rajan R. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer. Am J Clin Oncol. 2009;32:333–7.

Article  Google Scholar 

Anderson JK, Alanee S, Lindgren B, Slaton J. The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database. Urol Oncol. 2013;31:862–5.

Article  Google Scholar 

Khanal A, Budhathoki N, Singh VP, Shah BK. Second primary malignancy in bladder carcinoma—a population-based study. Anticancer Res. 2017;37:2033–6.

Article  Google Scholar 

Gotay CC, Ransom S, Pagano IS. Quality of life in survivors of multiple primary cancers compared with cancer survivor controls. Cancer. 2007;110:2101–9.

Article  Google Scholar 

Kulkarni GS, Hermanns T, Wei Y, Bhindi B, Satkunasivam R, Athanasopoulos P, et al. Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic. JCO. 2017;35:2299–305.

Article  Google Scholar 

Huddart RA, Birtle A, Maynard L, Beresford M, Blazeby J, Donovan J, et al. Clinical and patient-reported outcomes of SPARE—a randomised feasibility study of selective bladder preservation versus radical cystectomy. BJU Int. 2017;120:639–50.

CAS  Article  Google Scholar 

Efstathiou JA, Bae K, Shipley WU, Kaufman DS, Hagan MP, Heney NM, et al. Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89–03, 95–06, 97–06, 99–06. J Clin Oncol. 2009;27:4055–61.

CAS  Article  Google Scholar 

Miyanaga NAH, Shinohara N, Koyanagi T, Tsujino S, Miki M, Tobisu K, Niimi M, Hinotsu J. Assessment of QOL and survival for patients undergoing radical cystectomy or bladder preservation for invasive bladder cancer. Nihon Hinyokika Gakkai Zasshi. 1999;90:445–53.

CAS  PubMed  Google Scholar 

Singer S, Ziegler C, Schwalenberg T, Hinz A, Gotze H, Schulte T. Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer. Support Care Cancer. 2013;21:1383–93.

CAS  Article  Google Scholar